BeStock  

Elanco Animal Health ELAN

US equityMarket cap rank #1233Drug Manufacturers - Specialty & Generic
$25.74 −$0.55 (-2.09%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $25.22 -2.04%
Open$26.22
Prev close$26.29
Day range$25.58 – $26.93
Volume5.83M
Market cap$12.87B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.27B+11.3% YoY
Operating profit$84.00M+211.1% YoY
Net profit$18.00M+152.9% YoY
Diluted EPS$0.04+157.1% YoY
Free cash flow$156.00M+22.8% YoY
Operating cash flow$216.00M

Revenue, last 8 quarters

$1.0BDec '24$1.2BMar '25$1.2BJun '25$1.1BSep '25$1.1BDec '25$1.4BMar '26$1.4BJun '26$1.3BSep '26

Net profit, last 8 quarters

$-8.0MDec '24$67.0MMar '25$11.0MJun '25$-34.0MSep '25$-276.0MDec '25$57.0MMar '26$54.0MJun '26$18.0MSep '26

Diluted EPS by quarter

-0.02Dec '240.13Mar '250.02Jun '25-0.07Sep '25-0.56Dec '250.11Mar '260.11Jun '260.04Sep '26

Free cash flow by quarter

$130.0MDec '24$-69.0MMar '25$180.0MJun '25$127.0MSep '25$46.0MDec '25$-38.0MMar '26$244.0MJun '26$156.0MSep '26

Annual revenue

$3.3BFY20$4.8BFY21$4.4BFY22$4.4BFY23$4.4BFY24$4.7BFY25

Profitability & balance sheet

Gross margin56.2%
Operating margin7.6%
Net margin-2.9%
Return on equity-2.2%
Return on assets-1.1%
Return on invested capital0.1%
Current ratio2.09
Liabilities / assets50.3%
Cash & investments$465.00M
Total debt$3.71B
Net cash (debt)-$3.24B
Free cash flow / sales7.9%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.27B $1.37B $1.37B $4.72B $1.14B
Total Operating Revenue $1.27B $1.37B $1.37B $4.72B $1.14B
Cost of Revenue $545.00M $570.00M $586.00M $2.12B $555.00M
Gross Profit $720.00M $798.00M $785.00M $2.59B $589.00M
Operating Expense $636.00M $680.00M $616.00M $2.34B $570.00M
Selling and Admin Expenses $393.00M $449.00M $381.00M $1.43B $338.00M
Research & Development $99.00M $92.00M $97.00M $368.00M $93.00M
Depreciation & Amortization & Depletion $144.00M $139.00M $138.00M $543.00M $139.00M
-Depreciation & Amortization $144.00M $139.00M $138.00M $543.00M $139.00M
Operating Profit $84.00M $118.00M $169.00M $252.00M $19.00M
Net Non-Operating Interest Income (Expense) -$59.00M -$59.00M -$57.00M -$220.00M -$80.00M
Non-Operating Interest Expense $59.00M $59.00M $57.00M $220.00M $80.00M
Other Income (Expense) -$1.00M -$3.00M -$25.00M -$256.00M -$198.00M
Special Income (Charges) -$3.00M -$9.00M -$16.00M -$237.00M -$202.00M
-Less:Restructuring and Mergern & Acquisition $3.00M $5.00M $14.00M $119.00M $116.00M
-Less:Impairment of Capital Assets $0.00 – – $71.00M $47.00M
Other Non-Operating Income (Expenses) $2.00M $6.00M -$9.00M -$19.00M $4.00M
Pretax Profit $24.00M $56.00M $87.00M -$224.00M -$259.00M
Tax $6.00M $2.00M $30.00M $8.00M $17.00M
Net Profit $18.00M $54.00M $57.00M -$232.00M -$276.00M
Profit from Continuing Operations $18.00M $54.00M $57.00M -$232.00M -$276.00M
Net Income to Parent Company $18.00M $54.00M $57.00M -$232.00M -$276.00M
Net Income to Common Stockholders $18.00M $54.00M $57.00M -$232.00M -$276.00M
Basic EPS $0.04 $0.11 $0.11 -$0.47 -$0.56
Diluted EPS $0.04 $0.11 $0.11 -$0.47 -$0.56
-Less:Other Special Charges – $4.00M $2.00M $8.00M $0.00
-Less:Write Off – – – $39.00M –
-Gain on Sale Of Business – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $13.34B $13.56B $13.22B $13.36B $13.36B
Total Current Assets $3.73B $3.80B $3.58B $3.46B $3.46B
Cash and Cash Equivalents & Short-Term Investments $465.00M $530.00M $428.00M $545.00M $545.00M
-Cash and Cash Equivalents $465.00M $530.00M $428.00M $545.00M $545.00M
Receivables $1.06B $1.15B $1.15B $940.00M $940.00M
-Accounts Receivable $992.00M $1.08B $1.08B $873.00M $873.00M
-Other Receivables $71.00M $75.00M $70.00M $67.00M $67.00M
Inventory $1.82B $1.77B $1.72B $1.74B $1.74B
Other Current Assets $380.00M $346.00M $285.00M $236.00M $236.00M
Total Non-Current Assets $9.61B $9.76B $9.64B $9.90B $9.90B
Net PPE $1.44B $1.41B $1.40B $1.41B $1.41B
Goodwill and Other Intangible Assets $7.83B $8.05B $7.95B $8.19B $8.19B
-Goodwill $4.80B $4.85B $4.72B $4.78B $4.78B
-Other Intangible Assets $3.03B $3.20B $3.23B $3.41B $3.41B
Other Non-Current Assets $347.00M $304.00M $295.00M $304.00M $304.00M
Total Liabilities $6.71B $6.97B $6.72B $6.81B $6.81B
Total Current Liabilities $1.79B $1.85B $1.66B $1.60B $1.60B
Payables $416.00M $427.00M $372.00M $368.00M $368.00M
-Accounts Payable $416.00M $427.00M $372.00M $368.00M $368.00M
Short-Term Debt and Capital Lease Obligation $74.00M $73.00M $73.00M $74.00M $74.00M
-Current Debt $74.00M $73.00M $73.00M $74.00M $74.00M
Current Deferred Liabilities $443.00M $450.00M $400.00M $416.00M $416.00M
Other Current Liabilities $854.00M $902.00M $817.00M $533.00M $533.00M
Total Non-Current Liabilities $4.93B $5.12B $5.06B $5.21B $5.21B
Long Term Debt and Capital Lease Obligation $3.63B $3.85B $3.92B $3.94B $3.94B
-Long Term Debt $3.63B $3.85B $3.92B $3.94B $3.94B
Non-Current Deferred Liabilities $424.00M $410.00M $366.00M $382.00M $382.00M
Other Non-Current Liabilities $559.00M $551.00M $467.00M $427.00M $427.00M
Total Equity $6.63B $6.59B $6.50B $6.55B $6.55B
Stockholders' Equity $6.63B $6.59B $6.50B $6.55B $6.55B
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $8.90B $8.88B $8.86B $8.87B $8.87B
Retained Earnings -$2.05B -$2.07B -$2.13B -$2.18B -$2.18B
Gains/Losses Not Affecting Retained Earnings -$217.00M -$219.00M -$233.00M -$141.00M -$141.00M
-Gross PPE – – – $2.36B $2.36B
-Accumulated Depreciation – – – -$952.00M -$952.00M
Employee Benefits – – – $158.00M $158.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $216.00M $277.00M $13.00M $560.00M $108.00M
Net cash flow from continuing operations $216.00M $277.00M $13.00M $560.00M $108.00M
Net Income from Continuing Operations $18.00M $54.00M $57.00M -$232.00M -$276.00M
Depreciation & Depletion & Amortization $177.00M $171.00M $172.00M $680.00M $174.00M
Other Non-Cash Items $29.00M $8.00M $26.00M $8.00M $56.00M
Change in Working Capital -$31.00M $24.00M -$263.00M $99.00M $225.00M
Net cash flow from investing -$62.00M -$110.00M -$60.00M -$279.00M -$64.00M
Net Cash Flow from Continuing Investing Activities -$62.00M -$110.00M -$60.00M -$279.00M -$64.00M
Net PPE Purchase and Sale -$60.00M -$33.00M -$51.00M -$276.00M -$62.00M
Net Business Purchase and Sale $0.00 -$76.00M $0.00 $9.00M $0.00
Net Other Investing Changes -$2.00M -$1.00M -$9.00M -$12.00M -$2.00M
Financing Cash Flow -$216.00M -$74.00M -$65.00M -$275.00M -$18.00M
Net Cash Flow from Continuing Financing Activities -$216.00M -$74.00M -$65.00M -$275.00M -$18.00M
Net Issuance Payments Of Debt -$215.00M -$73.00M -$16.00M -$563.00M -$1.00M
Net Common Stock Issuance -$1.00M -$1.00M -$34.00M – –
Net Other Financing Charges $0.00 $0.00 -$15.00M $288.00M -$31.00M
Ending Cash Balance $465.00M $530.00M $428.00M $545.00M $545.00M
Net Change in Cash -$62.00M $93.00M -$112.00M $6.00M $26.00M
Beginning Cash Balance $530.00M $428.00M $545.00M $468.00M $505.00M
Effect of Exchange Rate Changes -$3.00M $9.00M -$5.00M $71.00M $14.00M
Free Cash Flow $156.00M $244.00M -$38.00M $284.00M $46.00M
Deferred Tax – – – -$134.00M –
-Change in Receivables – – – -$12.00M –
-Change in Inventory – – – -$57.00M –
-Change in Payables and Accrued Expense – – – $147.00M –
-Change in Other Current Assets – – – $21.00M –

Discussion

No comments yet — be the first to weigh in on ELAN.

Sign in to join the discussion.

Scroll to Top